HYMTF yields 1.40% · JNJ yields 2.13%● Live data
📍 HYMTF pulled ahead of the other in Year 1
Combined, HYMTF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of HYMTF + JNJ for your $10,000?
Hyundai Motor Company, together with its subsidiaries, manufactures and distributes motor vehicles and parts worldwide. It operates through Vehicle, Finance, and Others segments. The company offers cars under the Azera, Sonata, Veloster, Veloster N, i30 Fastback N, The new i30, i30 N, The all-new Elantra, Accent, i20 N, i20, The all-new Elantra N, and i10 names; and SUVs under the Palisade, Santa Fe, The all-new Tucson, Creta, The new Kona, KONA N, and Venue names. It also provides commercial vehicles under the STARIA, H-1, and H-100 names; and eco vehicles under the IONIQ 5, NEXO, Santa Fe Hybrid/Plug-in Hybrid, The all-new Tucson Hybrid, The all-new Tucson Plug-in Hybrid, KONA Electric, The all-new Elantra Hybrid, IONIQ Plug-in Hybrid, IONIQ Electric, IONIQ Hybrid, and The new i30 Hybrid names. In addition, the company offers trucks, buses, vans, engines; vehicle financing, credit card processing, and other financing activities; train manufacturing services and other activities; and marketing, engineering, mobility, and insurance services, as well as operates a football club. Further, it is involved in real estate development; research and development; and investment activities. Hyundai Motor Company was incorporated in 1967 and is headquartered in Seoul, South Korea.
Full HYMTF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.